X

Thank you for sharing!

Your article was successfully shared with the contacts you provided.

LEXINGTON, MA-A community becoming known as a destination for life-sciences companies has scored another victory, as Concert Pharmaceuticals extends its occupancy at One Ledgemont Center for seven years. The firm is also expanding substantially, reportedly taking 40,000 sf in the building after previously leasing a fraction of that amount.

“That’s a done deal,” one source tells GlobeSt.com, although no official acknowledgement has been issued. Broker John Boyle of DTZ FHO Partners referred calls to the Beal Cos., owners of Ledgemont Center, which were not returned by press deadline. Boyle and DTZ FHO colleague Kimberly Roop reportedly represented the landlord. Concert Pharmaceuticals broker Neil Schneider of McCall & Almy also did not respond to inquiries from GlobeSt.com.

The source tracking the lease negotiations notes that it removes one of the last remaining blocks of existing laboratory product in the Route 128 Central belt. Led by the defection of Shire Pharmaceuticals from Cambridge into approximately 400,000 sf at the Lexington Technology Park, other major life sciences deals signed in the submarket in recent months include Altus Pharmaceuticals leasing 85,000 sf at 610 Lincoln St. in Waltham; ImmunoGen Corp. securing 88,000 sf at 830 Winter St. in Waltham; and Microbia taking 40,000 sf at 60 Westview St. in Lexington. In its just released Biotech REview report, Colliers Meredith & Grew says nearly 750,000 sf of laboratory space has been leased or is about to along the Route 128 corridor since last summer.

CM&G puts the overall vacancy rate for 5.1 million sf of suburban laboratory space at 9.1%, down sharply from 17.1% at mid-year 2007. The defection of Cambridge companies has been a big reason, as tenants seek to escape tight supply and rents running up to $70 per sf. While suburban pricing has risen, CM&G estimates that space in that market ranges from $25 to $43 per sf, depending on age, location and quality.

Although the surge of activity has been unprecedented in the past year for Route 128 lab space, the concept is nothing new to Ledgemont Ctr., which is considered one of the first suburban alternatives for life sciences companies. The Beal Cos. has been promoting such a use since acquiring Ledgemont Center in the 1980s, feeding off the park’s close proximity to Cambridge.

Financial terms of the Concert Pharmaceuticals lease were not available. Beal has secured several other deals there recently, with medical device concern Tepha Inc. taking 20,000 sf at One Ledgemont Ctr. and Pulmatrix leasing 15,000 sf.

Want to continue reading?
Become a Free ALM Digital Reader.

Once you are an ALM digital member, you’ll receive:

  • Unlimited access to GlobeSt and other free ALM publications
  • Access to 15 years of GlobeSt archives
  • Your choice of GlobeSt digital newsletters and over 70 others from popular sister publications
  • 3 free articles* across the ALM subscription network every 30 days
  • Exclusive discounts on ALM events and publications

*May exclude premium content
Already have an account?

Dig Deeper

GlobeSt

Join GlobeSt

Don't miss crucial news and insights you need to make informed commercial real estate decisions. Join GlobeSt.com now!

  • Free unlimited access to GlobeSt.com's trusted and independent team of experts who provide commercial real estate owners, investors, developers, brokers and finance professionals with comprehensive coverage, analysis and best practices necessary to innovate and build business.
  • Exclusive discounts on ALM and GlobeSt events.
  • Access to other award-winning ALM websites including ThinkAdvisor.com and Law.com.

Already have an account? Sign In Now
Join GlobeSt

Copyright © 2020 ALM Media Properties, LLC. All Rights Reserved.